![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/11/20/2783148/16626/en/Zevra-Therapeutics-Completes-Acquisition-of-Acer-Therapeutics-in-its-Journey-to-Become-a-Leading-Rare-Disease-Company.html
https://www.globenewswire.com//news-release/2023/11/02/2772310/0/en/Leading-Independent-Proxy-Advisory-Firms-ISS-and-Glass-Lewis-Recommend-Acer-Therapeutics-Shareholders-Vote-FOR-the-Proposed-Merger-and-Related-Proposals.html
https://www.globenewswire.com//news-release/2023/08/30/2734780/0/en/Acer-Therapeutics-Reacquires-Worldwide-Development-Commercialization-and-Economic-Rights-to-OLPRUVA-from-Relief-Therapeutics-Excluding-the-Geographical-Europe.html
https://www.globenewswire.com/news-release/2023/08/14/2725006/0/en/Acer-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2023/06/26/2694449/0/en/Acer-Therapeutics-Receives-1-Million-Capital-Infusion-from-Chief-Executive-Officer-and-Founder.html
https://www.globenewswire.com/news-release/2023/05/15/2669410/0/en/Acer-Therapeutics-Reports-Q1-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2023/05/01/2658303/0/en/Acer-Therapeutics-Announces-OLPRUVA-Commercial-Launch-Progressing-Ahead-of-Schedule.html
https://www.globenewswire.com/news-release/2023/03/27/2635212/0/en/Acer-Therapeutics-Reports-Q4-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2023/03/22/2632193/0/en/Acer-Therapeutics-Announces-Data-Presented-at-Society-for-Inherited-Metabolic-Disorders-Annual-Meeting-Identifying-Preferred-Urea-Cycle-Disorder-Treatment-Attributes.html